This scoping review examines the barriers and enablers to accessing medical cannabis in Australia.

Clinical trials and laboratory studies provide evidence of anxiolytic effects of cannabidiol in healthy volunteers and clinical populations.

Medicinal cannabis is generally well tolerated, but the science related to its potential adverse effects is in its infancy.